Experts Matter. Find Yours.

Connect for media, speaking, professional opportunities & more.

Filters

Glen Hodgson

Glen Hodgson

Senior Vice-President and Chief EconomistThe Conference Board of Canada

Turning the Telescope Around: Get the bigger picture on how macroeconomics influences public policy and the financial health of your country

Economic ForecastingInternational BusinessProductivity and InnovationEconomic Analysis
Samantha Bradshaw

Samantha Bradshaw

Doctor of Philosophy CandidateOxford Internet Institute

Samantha Bradshaw is a D. Phil. candidate at the Oxford Internet Institute, working on the Computational Propaganda project.

GovernmentInternet GovernanceCyber SecuritySocial Media and DemocracyComputational Propaganda
Ari Lightman

Ari Lightman

ProfessorCarnegie Mellon University

Ari Lightman has 20 years of experience in new technology development and commercialization.

Emerging TechnologiesTechnology DevelopmentGeneration ZSocial NetworksCommercialization
Bridget Ross

Bridget Ross

CEOChroniSense Medical

Bridget Ross is a medical devices and pharmaceutical industry expert offering strategic advice and cross-functional team leadership.

Business StrategyCommercializationGeneral SurgeryUrologyDigital Health
Henry Kay

Henry Kay

Angel Investor and Board MemberBoston Harbor Angels

Henry Kay is on the Boards of Directors of several Life science companies in the US and Canada and is an active angel investor.

CommercializationMedical DevicesInvestingVenture CapitalStrategy
Ginger Grant

Ginger Grant

Professor (Marketing and Innovation)Sheridan College

Innovation Management, Leadership Development, Strategy, Corporate Anthropology, Organizational Design, Scenario Planning, Storytelling

Experiential and Archetypal MarketingScenario PlanningRevisioning RetirementInnovation CultureDesign Thinking
Chris Tam PhD

Chris Tam PhD

Co-Founder & CEOIntegrated Nanotherapeutics

Maximizing the therapeutic potential of drugs through nanotechnology.

NanoparticlesNanomedicineHealthcareNanotechnologyBiochemistry
Steve Edgett

Steve Edgett

CEOGenomadix

Steve Edgett has more than 20 years of experience in business development, strategic planning, and international markets.

Communications TechnologiesInternational MarketsStrategic PlanningNew MarketsBusiness Strategy
Michael Ehrlich

Michael Ehrlich

Associate Professor of Finance and Co-Director of NJ Innovation Acceleration CenterNew Jersey Institute of Technology

Professor Ehrlich's research focuses on financial markets and institutions, with an emphasis on market failures

InnovationCommercialization of InnovationMarket FailuresFinancial CrisesFinancial Markets
Gerry Brunk

Gerry Brunk

Managing DirectorLumira Ventures

Gerry Brunk is a venture capital investor with expertise in biotechnology, medical devices, start-ups and corporate strategy.

Business StrategyMedical DevicesPharmaceutical IndustryDrug DevelopmentCommercialization